13F Holdings
中文EN

SEPN Septerna, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1984086 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY336.7%
TTM net income YoY-0.3%
TTM EPS YoY-109.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-76.2%
Net margin-61.3%
FCF margin-80.6%
EBITDA margin-74.6%

Returns

ROE-14.4%
ROA-9.6%
ROIC (approx.)-35.2%
Asset turnover0.16x

Leverage & solvency

Liabilities / assets30.9%
Debt / equity0.00x
Current ratio4.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.30x
Accruals ratio2.9%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$45.95M$1.07M$151,000
R&D expense$97.58M$65.34M$35.98M
SG&A expense$29.16M$16.56M$9.72M
Operating income-$68.30M-$80.82M$2.08M
Pretax income-$48.87M-$72.30M-$48.87M
Income tax$12,000-$498,000$691,000
Net income-$48.88M-$71.80M$4.18M
EBITDA-$66.70M-$79.42M$2.88M
EPS (basic)-1.10-7.260.29
EPS (diluted)-1.10-7.260.29
Weighted avg. shares (diluted)44.26M9.89M2.18M
Balance sheet
Cash & equivalents$120.72M$238.20M$88.48M
Short-term investments$270.37M$112.73M$0
Receivables$10.36M$171,000$151,000
Current assets$410.96M$356.82M$112.68M
PP&E, net$4.43M$5.09M$4.67M
Total assets$596.19M$456.55M$130.87M
Current liabilities$86.93M$12.85M$6.91M
Total liabilities$214.26M$36.51M$20.03M
Shareholders' equity$381.93M$420.05M-$38.37M
Shares outstanding44.81M44.42M3.17M
Cash flow statement
Operating cash flow$110.19M-$67.47M-$38.72M
Capital expenditure$518,000$2.10M$2.88M
Free cash flow$109.67M-$69.57M-$41.60M
Investing cash flow-$229.35M-$160.60M$22.12M
Financing cash flow$1.69M$377.78M$74.52M
Depreciation & amortization$1.60M$1.40M$800,000
Stock-based compensation$8.48M$3.15M$1.62M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.